Análisis Argos
OMCL
OMCLEn su precio
Omnicell, Inc. · Healthcare
US$ 45.24
precio al 2026-07-07
Valor justo Argos*
US$ 44–49
vs. su valor justo
7% por debajo
Score Argos
60/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (1.7%) en línea con lo que la empresa demuestra (2.6%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
✓Cotiza 16% por debajo de su valor justo.
Riesgos
!Crecimiento estancado o en baja.
VALOR3/6FUTURO2/6PASADO2/6SALUD3/6DIVIDENDO4/6
El Iris de calidad
VALOR3/6FUTURO2/6PASADO2/6SALUD3/6DIVIDENDO4/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos60de 100En su precio
Ingresos▲6%
US$ 1.2 B
Margen operativo
1%
Flujo de caja libre▼40%
US$ 0.1 B
Deuda neta
US$ 0 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.1B
P/E1002.7x
EV/EBITDA21x
FCF yield4.2%
ROIC0.5%
Margen operativo1%
Crecim. ingresos+6.5%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 7 jul
What's Fueling Omnicell Stock's 52.6% Rally Over the Past Year?
Shares of Omnicell OMCL have rallied 52.6% over the past year, significantly outperforming the industry's 20.8% fall and the S&P 500 composite's 23.9% gain.
businesswire.com · 1 jul
Nnamdi Njoku Appointed President of Omnicell
FORT WORTH, Texas--(BUSINESS WIRE)--Nnamdi Njoku appointed President of Omnicell leading global operations & innovation strategy; Randall Lipps continues as CEO, Chairman of the Board.
zacks.com · 30 jun
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com · 26 jun
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.com · 24 jun
Do Options Traders Know Something About Omnicell Stock We Don't?
Investors need to pay close attention to OMCL stock based on the movements in the options market lately.
zacks.com · 10 jun
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks is more attractive to value investors?
zacks.com · 10 jun
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
seekingalpha.com · 9 jun
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Omnicell, Inc. (OMCL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.